• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

到2030年消除宫颈癌目标:六个非洲国家的基线评估——第二部分

Targeting elimination of cervical cancer by 2030: a baseline assessment in six African countries-part II.

作者信息

Stefan Daniela Cristina, Dangou Jean-Marie, Barango Prebo, Mahamadou Issimouha Dille, Kapambwe Sharon

机构信息

Institute of Global Health Equity Research Rwanda, University of Global Health Equity, 0000 Kigali, Rwanda.

World Health Organization Regional Office for Africa, P.O. Box: 06, Brazzaville, Republic of Congo.

出版信息

Ecancermedicalscience. 2022 Oct 7;16:1454. doi: 10.3332/ecancer.2022.1454. eCollection 2022.

DOI:10.3332/ecancer.2022.1454
PMID:36405933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9666272/
Abstract

BACKGROUND

Africa is home to many countries with the highest incidence of cervical cancer in the world. It is encouraging to see that the efforts to prevent and manage this disease are intensifying across the continent. The World Health Organization (WHO) has, in the last years, led a world-wide initiative to eliminate cervical cancer as a public health problem, starting by setting clear targets for 2030.

AIM

To assist those African countries with the largest burden of cervical cancer, to reach the set targets, as a first step, WHO initiated a baseline capacity assessment in African high burden countries. We present and discuss the results thereof in this paper.

METHOD

The countries selected for the baseline evaluation were Eswatini, Guinea, Malawi, Rwanda, Uganda and Zambia. The data were collected by a mailed questionnaire in English, with 129 questions, most of them with preset answer options. It was answered by national coordinators of non-communicable diseases, cancer control or reproductive health programmes in the ministries of health and by the WHO country representatives. Based on the answers, suggestions were made towards optimising the efforts for cancer control.

RESULTS

Except for Eswatini and Guinea, vaccination against the human papilloma virus (HPV) has reached between 74% and 98% of girls in the age bracket. The main method for cervical screening is still inspection with acid acetic. HPV testing, recommended by WHO, is being introduced slowly. The numbers of women screened are not yet nearing the required levels. Between 30% and 70% of the cervical cancers diagnosed are being treated with palliative intent. A deficit of personnel was reported for all professions involved in cervical cancer care.

CONCLUSIONS

Guinea will need assistance to implement HPV immunisations and expand screening. In all six countries surveyed, steps should be taken to introduce or scale up the more precise HPV screening instead of acid acetic inspection of the cervix, to replace the current cryoablation of the preinvasive lesions of the cervix with thermal ablation and to increase the capacity for screening. Solutions need to be found for covering the dearth in gynaecological oncologists and radiotherapy installations and personnel.

摘要

背景

非洲有许多国家是世界上宫颈癌发病率最高的国家。令人鼓舞的是,整个非洲大陆预防和管理这种疾病的努力正在加强。世界卫生组织(WHO)在过去几年中牵头开展了一项全球倡议,旨在消除宫颈癌这一公共卫生问题,首先为2030年设定了明确目标。

目的

为帮助那些宫颈癌负担最重的非洲国家实现既定目标,作为第一步,WHO在非洲高负担国家启动了基线能力评估。我们在本文中展示并讨论评估结果。

方法

选定进行基线评估的国家有斯威士兰、几内亚、马拉维、卢旺达、乌干达和赞比亚。数据通过一份英文邮寄问卷收集,问卷有129个问题,大多数问题有预设答案选项。由各国卫生部非传染性疾病、癌症控制或生殖健康项目的国家协调员以及WHO国家代表作答。根据答案,提出了优化癌症控制工作的建议。

结果

除斯威士兰和几内亚外,人乳头瘤病毒(HPV)疫苗接种率在该年龄段女孩中达到了74%至98%。宫颈癌筛查的主要方法仍然是醋酸检查。WHO推荐的HPV检测正在缓慢引入。接受筛查的女性人数尚未接近所需水平。确诊的宫颈癌患者中有30%至70%正在接受姑息治疗。据报告,参与宫颈癌护理的所有专业人员都存在短缺。

结论

几内亚在实施HPV免疫接种和扩大筛查方面需要援助。在所有六个接受调查的国家,应采取措施引入或扩大更精确的HPV筛查,而不是宫颈醋酸检查,用热消融取代目前对宫颈浸润前病变的冷冻消融,并提高筛查能力。需要找到解决妇科肿瘤学家以及放疗设备和人员短缺的办法。

相似文献

1
Targeting elimination of cervical cancer by 2030: a baseline assessment in six African countries-part II.到2030年消除宫颈癌目标:六个非洲国家的基线评估——第二部分
Ecancermedicalscience. 2022 Oct 7;16:1454. doi: 10.3332/ecancer.2022.1454. eCollection 2022.
2
The World Health Organization targets for cervical cancer control by 2030: a baseline assessment in six African countries-part I.世界卫生组织到2030年宫颈癌控制目标:六个非洲国家的基线评估——第一部分
Ecancermedicalscience. 2022 Oct 7;16:1453. doi: 10.3332/ecancer.2022.1453. eCollection 2022.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.2020 年全球宫颈癌发病率和死亡率估计:世卫组织全球消除宫颈癌倡议的基线分析。
Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.
5
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.在 181 个国家/地区扩大人乳头瘤病毒疫苗接种和宫颈癌筛查的影响,以及在 2020-99 年全球消除宫颈癌的可能性:一项建模研究。
Lancet Oncol. 2019 Mar;20(3):394-407. doi: 10.1016/S1470-2045(18)30836-2. Epub 2019 Feb 19.
6
Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening.评估艾滋病毒对南非消除宫颈癌的影响:疫苗接种和筛查影响的比较建模
EClinicalMedicine. 2022 Nov 17;54:101754. doi: 10.1016/j.eclinm.2022.101754. eCollection 2022 Dec.
7
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.HPV 疫苗接种和宫颈筛查对宫颈癌消除的影响:78 个低收入和中低收入国家的比较建模分析。
Lancet. 2020 Feb 22;395(10224):575-590. doi: 10.1016/S0140-6736(20)30068-4. Epub 2020 Jan 30.
8
Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.利用现有核酸检测平台进行人乳头瘤病毒检测,以筛查宫颈癌女性:来自撒哈拉以南非洲五个国家的实施研究。
BMJ Open. 2023 Jan 6;13(1):e065074. doi: 10.1136/bmjopen-2022-065074.
9
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.实现世界卫生组织宫颈癌消除目标的死亡率影响:78 个低收入和中低收入国家的比较建模分析。
Lancet. 2020 Feb 22;395(10224):591-603. doi: 10.1016/S0140-6736(20)30157-4. Epub 2020 Jan 30.
10
Case study of cervical cancer prevention in two sub-Saharan African countries: Rwanda and Sierra Leone.撒哈拉以南非洲两个国家(卢旺达和塞拉利昂)宫颈癌预防的案例研究。
Front Med (Lausanne). 2022 Sep 15;9:928685. doi: 10.3389/fmed.2022.928685. eCollection 2022.

引用本文的文献

1
Cervical cancer screening: a comparative study of TruScreen vs. Pap Smear.宫颈癌筛查:TruScreen与巴氏涂片的比较研究。
BMC Womens Health. 2025 Apr 21;25(1):198. doi: 10.1186/s12905-025-03733-z.
2
Access to brachytherapy treatment for cervical cancer management in Africa.非洲宫颈癌管理中近距离放射治疗的可及性。
Clin Transl Radiat Oncol. 2024 Oct 28;50:100880. doi: 10.1016/j.ctro.2024.100880. eCollection 2025 Jan.
3
Prevalence of Human Papillomavirus in Different Mucous Membranes in HIV Concordant Couples in Rwanda.卢旺达 HIV 一致夫妇不同黏膜中人乳头瘤病毒的流行情况。
Viruses. 2023 Apr 19;15(4):1005. doi: 10.3390/v15041005.
4
The World Health Organization targets for cervical cancer control by 2030: a baseline assessment in six African countries-part I.世界卫生组织到2030年宫颈癌控制目标:六个非洲国家的基线评估——第一部分
Ecancermedicalscience. 2022 Oct 7;16:1453. doi: 10.3332/ecancer.2022.1453. eCollection 2022.

本文引用的文献

1
The World Health Organization targets for cervical cancer control by 2030: a baseline assessment in six African countries-part I.世界卫生组织到2030年宫颈癌控制目标:六个非洲国家的基线评估——第一部分
Ecancermedicalscience. 2022 Oct 7;16:1453. doi: 10.3332/ecancer.2022.1453. eCollection 2022.
2
HPV vaccine cut cervical cancer rates in England by 87.人乳头瘤病毒疫苗使英国宫颈癌发病率降低了87%。
BMJ. 2021 Nov 5;375:n2689. doi: 10.1136/bmj.n2689.
3
Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such Treatment.调查改善非洲基于线性加速器的放射治疗所面临的挑战:一个独特的协作平台,涵盖了所有提供此类治疗的 28 个非洲国家。
Clin Oncol (R Coll Radiol). 2021 Dec;33(12):e521-e529. doi: 10.1016/j.clon.2021.05.008. Epub 2021 Jun 9.
4
The economic burden of cervical cancer in Eswatini: Societal perspective.斯威士兰宫颈癌的经济负担:社会视角。
PLoS One. 2021 Apr 15;16(4):e0250113. doi: 10.1371/journal.pone.0250113. eCollection 2021.
5
Gynecologic Oncology Sub-Specialty Training in Ghana: A Model for Sustainable Impact on Gynecologic Cancer Care in Sub-Saharan Africa.加纳妇科肿瘤亚专科培训:对撒哈拉以南非洲妇科癌症护理产生可持续影响的模式。
Front Public Health. 2020 Dec 3;8:603391. doi: 10.3389/fpubh.2020.603391. eCollection 2020.
6
Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women.模拟中国女性中在校女生人乳头瘤病毒(HPV)联合疫苗接种和宫颈癌筛查项目的流行病学影响及成本效益。
Hum Vaccin Immunother. 2021 Apr 3;17(4):1073-1082. doi: 10.1080/21645515.2020.1832835. Epub 2020 Dec 3.
7
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries.评估人乳头瘤病毒疫苗接种在符合 Gavi 资格的低收入和中等收入国家中的价值。
BMJ Glob Health. 2020 Oct;5(10). doi: 10.1136/bmjgh-2020-003006.
8
HPV Vaccination and the Risk of Invasive Cervical Cancer.HPV 疫苗接种与浸润性宫颈癌风险。
N Engl J Med. 2020 Oct 1;383(14):1340-1348. doi: 10.1056/NEJMoa1917338.
9
Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda.乌干达西部一项基于社区的宫颈癌筛查项目中高危型人乳头瘤病毒mRNA检测的患病率、关联因素及预测价值
Infect Agent Cancer. 2019 May 14;14:14. doi: 10.1186/s13027-019-0230-0. eCollection 2019.
10
Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination.撒哈拉以南非洲地区宫颈癌的预防:人乳头瘤病毒疫苗接种的优势与挑战
Vaccines (Basel). 2018 Sep 8;6(3):61. doi: 10.3390/vaccines6030061.